Finding
By Jenifer Goodwin, Freelance Writer  |  Thursday, February 6, 2014

Investigators have found a possible molecular explanation for why obese people with kidney cancer tend to fare better despite having a higher rate of diagnosis.

Pictured: Low-dose CT scans
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 26, 2013

The American Society of Clinical Oncology’s annual report on top clinical cancer advances of the year once again features several studies led by Memorial Sloan Kettering researchers.

Pictured: Robert J. Motzer
In the Clinic
By Maureen Salamon, BA, Freelance Writer  |  Thursday, August 22, 2013

An international study led by Memorial Sloan Kettering found that pazopanib (Votrient®) controls cancer as effectively as sunitinib (Sutent®) while improving patients’ quality of life.

Pictured: Pramod Sogani
Honor
By Media Staff  |  Monday, July 1, 2013

Memorial Sloan Kettering urologic surgeon Pramod Sogani has been inaugurated as President of the American Urological Association. In this Q&A he discusses his goals and his new role.

Pictured: Paul Russo
In the Clinic
By Media Staff  |  Monday, May 20, 2013

A study has found that the majority of kidney cancer patients with small tumors have their entire kidney removed, which can increase the risk of developing chronic kidney disease and cardiovascular complications.

Pictured: Robert Motzer & Suzanne Gornell
Video
By Allyson Collins, MS, Science Writer/Editor  |  Wednesday, May 8, 2013

Our experts have participated in or led the development of five of the seven drugs approved by the US Food and Drug Administration for patients with advanced kidney cancer since 2005.

Pictured: Guido Dalbagni
Video
By Memorial Sloan Kettering  |  Tuesday, April 23, 2013

Dr. Dalbagni – who cares for patients with bladder cancer, kidney cancer, penile cancer, and sarcomas – explains treatments offered at Memorial Sloan Kettering, which can help patients maintain their quality of life.

Pictured: Raul Parra
Video
By Memorial Sloan Kettering  |  Wednesday, March 6, 2013

Dr. Parra, who practices at Memorial Sloan Kettering Basking Ridge, treats prostate, kidney, and bladder cancers with the goal of extending the lives of patients, and giving them the best possible quality of life.

Pictured: David Finley & Maria Teresa Ruiz Tsukazan
Feature
By Celia Gittelson, BA  |  Monday, February 25, 2013

Our doctors introduce and apply advanced technologies in minimal-access surgery to benefit patients.

Pictured: Bernard Bochner
Video
By Memorial Sloan Kettering  |  Friday, January 11, 2013

Dr. Bochner – who specializes in treating people with prostate, bladder, and kidney cancers – discusses the importance of a multidisciplinary team approach to delivering high-quality care.

Pictured: X-ray Image
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Wednesday, December 19, 2012

Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.

Pictured: Karim Touijer
Video
By Memorial Sloan Kettering  |  Tuesday, July 31, 2012

Watch urologic surgeon Karim Touijer discuss our comprehensive approach to cancer care and recent advances in minimally invasive surgery.

Pictured: Robert Motzer
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor  |  Monday, May 21, 2012

Results of an international study indicate that the investigational drug tivozanib is more effective and better tolerated than a currently approved therapy in delaying cancer growth.

Pictured: Jonathan Coleman
Video
By Memorial Sloan Kettering  |  Monday, May 14, 2012

Dr. Coleman, who specializes in treating prostate and kidney cancers, talks about how minimally invasive surgical techniques reduce recovery time and pain, as well as improve quality of life for patients.

Pictured: Kidney CancerSmart Lecture
Video
By Memorial Sloan Kettering  |  Wednesday, March 28, 2012

March is Kidney Cancer Awareness Month. Watch the latest videos of our kidney cancer experts discussing advances in diagnosis and personalized treatment at our CancerSmart lecture series.

Center News

Stay Informed

Get the latest information about cancer care and research every month.